Cha Wonjae, Yoon Byung-Woo, Jang Jeon Yeob, Lee Jin Choon, Lee Byung Joo, Wang Soo-Geun, Cho Jae Keun, Cho Ilyoung
Department of Otorhinolaryngology-Head and Neck Surgery and Biomedical Research Institute, Pusan National University Hospital, Busan.
Department of Otorhinolaryngology-Head and Neck Surgery, School of Medicine, Pusan National University Yangsan Hospital, Yangsan, Gyeongsangnam-do.
Laryngoscope. 2016 Nov;126(11):2513-2519. doi: 10.1002/lary.25930. Epub 2016 Apr 26.
OBJECTIVES/HYPOTHESIS: Office-based biopsy (OBB) is widely used to diagnose suspicious laryngeal lesions. However, its routine use is still controversial and the algorithm for clinical strategy is not concrete. We tried to evaluate the accuracy of OBB as a diagnostic tool for laryngeal malignancy.
Medical data of 581 patients undergoing OBB were reviewed. Diagnostic values of OBB were analyzed for malignancy and malignancy/premalignancy. False negative rates (FNRs) were analyzed according to subsites, lesion sizes, and morphology.
The collection rate of adequate specimens was 99.1%, and there were no complications during OBB. The false omission rates for malignancy of benign lesion; mild, moderate, and severe dysplasia; and carcinoma in situ (CIS) were 5.1%, 11.9%, 14.3%, 50.0%, and 100.0%, respectively. Sensitivity, specificity, positive predictive value, and negative predictive value for malignancy in OBB were 78.2%, 100.0%, 100.0%, and 87.3%, respectively. Those for malignancy/premalignancy in OBB were 88.2%, 86.7%, 85.7%, and 89.1%, respectively. The high FNRs were reported in glottis lesions (27.0%) and small lesions below 1 cm (27.5%). Morphologically fungating lesions showed low FNR (9.1%) compared to nonfungating ones.
Office-based biopsy could be used as an initial diagnostic tool for laryngeal malignancy for early detection and avoidance of general anesthesia. However, operative re-biopsy should be considered when severe dysplasia or CIS were reported in OBB, or when the lesions are clinically suspicious for malignancy.
目的/假设:门诊活检(OBB)被广泛用于诊断可疑喉部病变。然而,其常规应用仍存在争议,临床策略算法也不具体。我们试图评估OBB作为喉恶性肿瘤诊断工具的准确性。
回顾了581例行OBB患者的医疗数据。分析了OBB对恶性肿瘤以及恶性肿瘤/癌前病变的诊断价值。根据亚部位、病变大小和形态分析假阴性率(FNR)。
充分标本采集率为99.1%,OBB过程中无并发症发生。良性病变、轻度、中度和重度发育异常以及原位癌(CIS)的恶性肿瘤假漏诊率分别为5.1%、11.9%、14.3%、50.0%和100.0%。OBB对恶性肿瘤的敏感性、特异性、阳性预测值和阴性预测值分别为78.2%、100.0%、100.0%和87.3%。OBB对恶性肿瘤/癌前病变的敏感性、特异性、阳性预测值和阴性预测值分别为88.2%、86.7%、85.7%和89.1%。声门区病变(27.0%)和1cm以下小病变(27.5%)的FNR较高。与非蕈状病变相比,形态学上呈蕈状的病变FNR较低(9.1%)。
门诊活检可作为喉恶性肿瘤的初步诊断工具,用于早期检测并避免全身麻醉。然而,当OBB报告为重度发育异常或CIS,或病变临床上怀疑为恶性时,应考虑进行手术再次活检。
4。《喉镜》,2016年,126卷:2513 - 2519页。